Credit Suisse AG Buys 363 Shares of Plexus Corp. (NASDAQ:PLXS)

Credit Suisse AG boosted its stake in Plexus Corp. (NASDAQ:PLXS – Get Rating) by 1.5% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 25,307 shares of the technology company’s stock after acquiring an additional 363 shares during the period. Credit Suisse AG owned 0.09% of Plexus worth $2,215,000 as of its most recent filing with the SEC.

Other hedge funds have also added to or reduced their stakes in the company. Millennium Management LLC raised its position in shares of Plexus by 609.5% in the second quarter. Millennium Management LLC now owns 38,207 shares of the technology company’s stock valued at $2,999,000 after purchasing an additional 32,822 shares during the period. Intrinsic Edge Capital Management LLC raised its position in shares of Plexus by 23.0% in the second quarter. Intrinsic Edge Capital Management LLC now owns 158,590 shares of the technology company’s stock valued at $12,449,000 after purchasing an additional 29,657 shares during the period. Invesco Ltd. raised its position in shares of Plexus by 8.1% in the first quarter. Invesco Ltd. now owns 305,347 shares of the technology company’s stock valued at $24,981,000 after purchasing an additional 22,947 shares during the period. Charles Schwab Investment Management Inc. raised its position in shares of Plexus by 4.6% in the first quarter. Charles Schwab Investment Management Inc. now owns 348,646 shares of the technology company’s stock valued at $28,523,000 after purchasing an additional 15,426 shares during the period. Finally, BlackRock Inc. raised its position in shares of Plexus by 0.3% in the first quarter. BlackRock Inc. now owns 4,425,537 shares of the technology company’s stock valued at $362,052,000 after purchasing an additional 15,398 shares during the period. Institutional investors own 96.01% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on PLXS shares. Sidoti raised shares of Plexus from a “neutral” rating to a “buy” rating and set a $116.00 price objective for the company in a research note on Friday, January 27th. JPMorgan Chase & Co. reduced their price objective on shares of Plexus from $90.00 to $86.00 and set an “underweight” rating for the company in a research note on Friday, January 27th. Finally, Needham & Company LLC reduced their price objective on shares of Plexus from $112.00 to $108.00 and set a “buy” rating for the company in a research note on Friday, January 27th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $107.00.

Plexus Price Performance

PLXS stock opened at $96.11 on Monday. The company has a debt-to-equity ratio of 0.16, a current ratio of 1.44 and a quick ratio of 0.60. Plexus Corp. has a one year low of $74.53 and a one year high of $115.36. The stock has a market cap of $2.66 billion, a PE ratio of 17.32 and a beta of 1.11. The firm has a 50 day simple moving average of $102.77 and a two-hundred day simple moving average of $99.55.

Plexus (NASDAQ:PLXS – Get Rating) last released its quarterly earnings results on Wednesday, January 25th. The technology company reported $1.49 EPS for the quarter, topping analysts’ consensus estimates of $1.47 by $0.02. Plexus had a net margin of 3.84% and a return on equity of 14.45%. The business had revenue of $1.09 billion during the quarter, compared to analysts’ expectations of $1.11 billion. During the same quarter in the previous year, the company earned $0.88 EPS. The business’s quarterly revenue was up 33.8% compared to the same quarter last year. On average, analysts predict that Plexus Corp. will post 5.6 EPS for the current fiscal year.

Plexus Company Profile

(Get Rating)

Plexus Corp. engages in the provision of electronic manufacturing services. The firm partners with companies to transform concepts into branded products and deliver them to the market. It has partnerships with customers in the healthcare and life sciences, industrial and commercial, communications, and aerospace and defense market sectors.